Literature DB >> 16631220

Sendai virus defective-interfering genomes and the activation of interferon-beta.

Laura Strahle1, Dominique Garcin, Daniel Kolakofsky.   

Abstract

The ability of some Sendai virus stocks to strongly activate IFNbeta has long been known to be associated with defective-interfering (DI) genomes. We have compared SeV stocks containing various copyback and internal deletion DI genomes (and those containing only nondefective (ND) genomes) for their ability to activate reporter genes driven by the IFNbeta promoter. We found that this property was primarily due to the presence of copyback DI genomes and correlated with their ability to self-anneal and form dsRNA. The level of IFNbeta activation was found to be proportional to that of DI genome replication and to the ratio of DI to ND genomes during infection. Over-expression of the viral V and C proteins was as effective in blocking the copyback DI-induced activation of the IFNbeta promoter as it was in reducing poly-I/C-induced activation, providing evidence that these DI infections activate IFNbeta via dsRNA. Infection with an SeV stock that is highly contaminated with copyback DI genomes is thus a very particular way of potently activating IFNbeta, presumably by providing plentiful dsRNA under conditions of reduced expression of viral products which block the host antiviral response.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16631220     DOI: 10.1016/j.virol.2006.03.022

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  115 in total

1.  Induction of IFN-α subtypes and their antiviral activity in mumps virus infection.

Authors:  Maja Markušić; Maja Šantak; Tanja Košutić-Gulija; Mladen Jergović; Renata Jug; Dubravko Forčić
Journal:  Viral Immunol       Date:  2014-12       Impact factor: 2.257

2.  Post-transcriptional inhibition of luciferase reporter assays by the Nod-like receptor proteins NLRX1 and NLRC3.

Authors:  Arthur Ling; Fraser Soares; David O Croitoru; Ivan Tattoli; Leticia A M Carneiro; Michele Boniotto; Szilvia Benko; Dana J Philpott; Stephen E Girardin
Journal:  J Biol Chem       Date:  2012-06-20       Impact factor: 5.157

3.  Paramyxovirus V proteins interact with the RNA Helicase LGP2 to inhibit RIG-I-dependent interferon induction.

Authors:  Kay Childs; Richard Randall; Stephen Goodbourn
Journal:  J Virol       Date:  2012-02-01       Impact factor: 5.103

4.  Loss of Sendai virus C protein leads to accumulation of RIG-I immunostimulatory defective interfering RNA.

Authors:  Maria Teresa Sánchez-Aparicio; Dominique Garcin; Charles M Rice; Daniel Kolakofsky; Adolfo García-Sastre; Alina Baum
Journal:  J Gen Virol       Date:  2017-06-20       Impact factor: 3.891

5.  Differential recognition of viral RNA by RIG-I.

Authors:  Alina Baum; Adolfo García-Sastre
Journal:  Virulence       Date:  2011-03-01       Impact factor: 5.882

Review 6.  Sensing of viral nucleic acids by RIG-I: from translocation to translation.

Authors:  Andreas Schmidt; Simon Rothenfusser; Karl-Peter Hopfner
Journal:  Eur J Cell Biol       Date:  2011-04-14       Impact factor: 4.492

7.  Cytokine-independent upregulation of MDA5 in viral infection.

Authors:  Jacob S Yount; Thomas M Moran; Carolina B López
Journal:  J Virol       Date:  2007-05-02       Impact factor: 5.103

8.  Regulation of signal transduction by enzymatically inactive antiviral RNA helicase proteins MDA5, RIG-I, and LGP2.

Authors:  Darja Bamming; Curt M Horvath
Journal:  J Biol Chem       Date:  2009-02-11       Impact factor: 5.157

9.  Highly immunostimulatory RNA derived from a Sendai virus defective viral genome.

Authors:  Xiomara Mercado-López; Christopher R Cotter; Won-Keun Kim; Yan Sun; Luis Muñoz; Karla Tapia; Carolina B López
Journal:  Vaccine       Date:  2013-10-05       Impact factor: 3.641

10.  Incoming RNA virus nucleocapsids containing a 5'-triphosphorylated genome activate RIG-I and antiviral signaling.

Authors:  Michaela Weber; Ali Gawanbacht; Matthias Habjan; Andreas Rang; Christoph Borner; Anna Mareike Schmidt; Sophie Veitinger; Ralf Jacob; Stéphanie Devignot; Georg Kochs; Adolfo García-Sastre; Friedemann Weber
Journal:  Cell Host Microbe       Date:  2013-03-13       Impact factor: 21.023

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.